WO2006136916A3 - Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same - Google Patents

Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same Download PDF

Info

Publication number
WO2006136916A3
WO2006136916A3 PCT/IB2006/001663 IB2006001663W WO2006136916A3 WO 2006136916 A3 WO2006136916 A3 WO 2006136916A3 IB 2006001663 W IB2006001663 W IB 2006001663W WO 2006136916 A3 WO2006136916 A3 WO 2006136916A3
Authority
WO
WIPO (PCT)
Prior art keywords
substantially pure
telmisartan
pharmaceutical compositions
micronized particles
compositions containing
Prior art date
Application number
PCT/IB2006/001663
Other languages
French (fr)
Other versions
WO2006136916A2 (en
Inventor
Narendra Shriram Joshi
Kodali Eswara Rao
Nitin S Pradhan
Original Assignee
Glenmark Pharmaceuticals Ltd
Narendra Shriram Joshi
Kodali Eswara Rao
Nitin S Pradhan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Ltd, Narendra Shriram Joshi, Kodali Eswara Rao, Nitin S Pradhan filed Critical Glenmark Pharmaceuticals Ltd
Publication of WO2006136916A2 publication Critical patent/WO2006136916A2/en
Publication of WO2006136916A3 publication Critical patent/WO2006136916A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient

Abstract

The present invention provides micronized particles of substantially pure telmisartan or a pharmaceutically acceptable salt, ester or derivative thereof. Also provided are pharmaceutical compositions containing the micronized particles of substantially pure telmisartan or a pharmaceutically acceptable salt, ester or derivative thereof.
PCT/IB2006/001663 2005-06-20 2006-06-20 Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same WO2006136916A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN717/MUM/2005 2005-06-20
IN717MU2005 2005-06-20
US69715305P 2005-07-07 2005-07-07
US60/697,153 2005-07-07

Publications (2)

Publication Number Publication Date
WO2006136916A2 WO2006136916A2 (en) 2006-12-28
WO2006136916A3 true WO2006136916A3 (en) 2007-05-18

Family

ID=37114401

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/001663 WO2006136916A2 (en) 2005-06-20 2006-06-20 Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same

Country Status (1)

Country Link
WO (1) WO2006136916A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2415357T3 (en) 2009-06-19 2013-07-25 Krka Tovarna Zdravil, D.D., Novo Mesto Procedure for the preparation of telmisartan
EP2305650A1 (en) * 2009-09-21 2011-04-06 Chemo Ibérica, S.A. Novel process for the preparation of telmisartan
CN103520125B (en) * 2013-09-28 2019-03-05 威海迪素制药有限公司 A kind of telmisartan composition

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0502314A1 (en) * 1991-02-06 1992-09-09 Dr. Karl Thomae GmbH Benzimidazol, medicaments containing them and process for their preparation
WO1999045779A1 (en) * 1998-03-11 1999-09-16 Smithkline Beecham Corporation Novel compositions of eprosartan
WO2000038676A1 (en) * 1998-12-23 2000-07-06 Novartis Ag Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors
US6410742B1 (en) * 1999-01-19 2002-06-25 Boehringer Ingelheim Pharma Kg Polymorphs of telmisartan
WO2004007482A2 (en) * 2002-07-16 2004-01-22 Teva Pharmaceutical Industries Ltd. Novel synthesis of irbesartan
US20040110813A1 (en) * 2002-09-24 2004-06-10 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
US20040236113A1 (en) * 2003-03-31 2004-11-25 Boehringer Ingelheim International Gmbh Process for manufacture of telmisartan
US20050070594A1 (en) * 2003-07-31 2005-03-31 Boehringer Ingelheim International Gmbh Use of angiotensin II receptor antagonists
WO2005108375A1 (en) * 2004-05-11 2005-11-17 Cipla Limited Process for the preparation of telmisartan

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0502314A1 (en) * 1991-02-06 1992-09-09 Dr. Karl Thomae GmbH Benzimidazol, medicaments containing them and process for their preparation
WO1999045779A1 (en) * 1998-03-11 1999-09-16 Smithkline Beecham Corporation Novel compositions of eprosartan
WO2000038676A1 (en) * 1998-12-23 2000-07-06 Novartis Ag Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors
US6410742B1 (en) * 1999-01-19 2002-06-25 Boehringer Ingelheim Pharma Kg Polymorphs of telmisartan
WO2004007482A2 (en) * 2002-07-16 2004-01-22 Teva Pharmaceutical Industries Ltd. Novel synthesis of irbesartan
US20040110813A1 (en) * 2002-09-24 2004-06-10 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
US20040236113A1 (en) * 2003-03-31 2004-11-25 Boehringer Ingelheim International Gmbh Process for manufacture of telmisartan
US20050070594A1 (en) * 2003-07-31 2005-03-31 Boehringer Ingelheim International Gmbh Use of angiotensin II receptor antagonists
WO2005108375A1 (en) * 2004-05-11 2005-11-17 Cipla Limited Process for the preparation of telmisartan

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BAUER, FRÖMMING, FÜHRER: "Lehrbuch der Pharmazeutischen Technologie", 1997, GUSTAV FISCHER VERLAG STUTTGART, XP002404966 *

Also Published As

Publication number Publication date
WO2006136916A2 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
WO2007146248A3 (en) Stable laquinimod preparations
WO2007027527A3 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
WO2007090882A3 (en) Pharmaceutical extended release compositions comprising pramipexole
IL189782A (en) Sulphonylpyrrole derivatives and pharmaceutical compositions containing the same and uses thereof
WO2006023627A8 (en) Rapamycin polymorph ii and uses thereof
MX2012007375A (en) 3-keto-n-propargyl-1-aminoindan.
SI3219705T1 (en) Pharmaceutical compositions of the amorphous form of n-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide
IL190249A0 (en) Deazapurine derivatives and pharmaceutical compositions containing the same
IL186738A0 (en) Pyrizole derivatives and pharmaceutical compositions containing the same
WO2007135527A3 (en) Benzimidazolyl compounds
IL183919A0 (en) Triazolophthalazine derivatives and pharmaceutical compositions containing the same
WO2006108572A3 (en) Novel crystalline pharmaceutical product
WO2005117895A8 (en) Compositions comprising meloxicam
WO2009066315A3 (en) Sustained release compositions of trimetazidine and process for preparation thereof
WO2008006795A3 (en) Indole compounds
TW200640861A (en) Amorphous lercanidipine hydrochloride
WO2007075794A3 (en) Oral formulations comprising tigecycline
AU2003245504A1 (en) Pharmaceutical compositions for drugs having ph-dependentsolubility
IL184996A0 (en) Dihydroimidazothiazole derivatives and pharmaceutical compositions containing the same
WO2008003050A3 (en) Gallium nitrate formulations
WO2008101173A3 (en) Biodegradable compositions and materials
WO2009026257A3 (en) Methods and compositions for controlling the bioavailability of poorly soluble drugs
AU2006243194A8 (en) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
AU2002356646A1 (en) Pharmaceutical compositions for the pulmonary delivery of aztreonam

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06779740

Country of ref document: EP

Kind code of ref document: A2